Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.670
0.00 (0.00%)
At close: Oct 7, 2026, 4:00 PM EDT
1.714
+0.044 (2.61%)
After-hours: Oct 7, 2026, 6:17 PM EDT
Gain Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
72.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 55.18K | -84.93K | -60.62% |
| Dec 31, 2022 | 140.11K | -24.89K | -15.08% |
| Dec 31, 2021 | 164.99K | 136.11K | 471.29% |
| Dec 31, 2020 | 28.88K | -12.42K | -30.07% |
| Dec 31, 2019 | 41.30K | 20.69K | 100.40% |
| Dec 31, 2018 | 20.61K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 60.66M |
| Spero Therapeutics | 47.00M |
| Verrica Pharmaceuticals | 30.32M |
| MindWalk Holdings | 11.57M |
| NeOnc Technologies Holdings | 39.99K |
GANX News
- 6 days ago - Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration - GlobeNewsWire
- 8 days ago - Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders - GlobeNewsWire
- 20 days ago - Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference - GlobeNewsWire
- 6 weeks ago - Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 1 month ago - Gain Therapeutics Earnings release: Q2 2026 - Filings
- 1 month ago - Gain Therapeutics Quarterly report: Q2 2026 - Filings
- 1 month ago - Gain Therapeutics reports Q2 EPS (11c), consensus (15c) - TheFly
- 2 months ago - Gain Therapeutics Slides: Corporate presentation - Filings